Post-Settlement Fosamax Funding

If you’re an attorney or plaintiff with a Fosamax settlement that is slow to payout, RD Legal Funding can help by converting your settled legal fee or award into immediate cash. Our post-settlement Fee Acceleration program was specifically designed to provide cash to plaintiff’s attorneys and their clientele when there is a delay in the distribution of settlement proceeds.

About Fosamax

Fosamax (generic: alendronate) is a drug intended to treat and prevent the bone-thinning and density loss associated with osteoporosis and Paget’s disease. Fosamax is a bisphosphonate, part of a class of drugs whose main function is to increase bone density and strength.

Recently, Fosamax has been under investigation by the FDA for its potential side effects, none of which have been disclosed or warned against by the manufacturer. Some of these potential side effects include nausea, bloating, and other gastrointestinal discomforts; difficulty tasting food and differentiating flavors; bloody vomit; swelling of gums, face, legs, and other body parts; and fever blisters. Other dangers that may be presented by Fosamax are an increased risk for breaking bones. The FDA is also conducting research to discover whether taking bisphosphonates leads to an increased risk of esophageal cancer, but so far, no definitive answers exist.

Multiple lawsuits have been launched against Merck, the manufacturers of Fosamax, by those who have been made sick or suffered fatalities as a result of Fosamax usage. One of the largest cases is made up of 1,140 plaintiffs who alleged that Fosamax led to osteonecrosis of the jaw (ONJ), or the death of a jaw bone. The FDA confirmed in 2004 that Fosamax increases the chances for this condition. In December, 2013, Merck said that it would pay $27.7 million to settle the ONJ suit. This settlement does not cover all of the 5,255 product liability lawsuits facing Merck over Fosamax.

FDA regulations as of 2010 required that Fosamax include warning labels against increased risk of bone fracture or breakage. This warning was released after a 2008 alert that bisphosphonates can cause joint, bone, and muscle pain. There are currently over 4,000 pending lawsuits against Merck. These claims are by and large consolidated into a multi-district litigation.

If you or someone you know have been affected by Fosamax, contact your attorney and see if you may be eligible to submit a claim.

Let RD Legal Funding Accelerate Your Post-Settlement Fosamax Fees

Even after a case is settled, unforeseen delays can prevent you from receiving your fees/award in a timely manner. Whether it’s a class action between preliminary and final approval or a personal injury case involving Medicare liens, RD Legal can help you access your hard earned fees faster. Our post-settlement financing solution is a quicker option with fewer qualifications than a line of credit.

For more information about post-settlement funding, please call RD Legal Funding, at 201-568-9007. If you’d like to begin the application process, please fill out the quick form on this page.



Apply Now for your free legal funding consultation
  • all fields required